Which acetylcholinesterase inhibitor was the first approved for Alzheimer disease but is rarely used due to hepatotoxicity?
Show answer and explanation
Correct answer: Tacrine
Tacrine was the first acetylcholinesterase inhibitor approved for Alzheimer disease. However, it is rarely used today due to its potential to cause liver toxicity.
Keep practicing
More Alzheimer Disease Drugs questions
- Which drug used in Alzheimer disease is available as a transdermal patch formulation?
- Which pathological feature is commonly associated with Alzheimer disease?
- Which drug used in Alzheimer disease works by reducing glutamate-mediated neurotoxicity?
- Which stage of Alzheimer disease is most commonly treated with acetylcholinesterase inhibitors?
- Which gastrointestinal side effect is frequently associated with acetylcholinesterase inhibitors?
- Which drug may be combined with donepezil in moderate to severe Alzheimer disease?